Hamartin, encoded by the TSC1 gene, is a pivotal protein in cellular regulation, acting as a tumor suppressor and a critical component of the TSC1/TSC2 complex. This complex plays a fundamental role in the regulation of the mammalian target of rapamycin (mTOR) pathway, which is essential for cell growth and proliferation. Hamartin's interaction with tuberin (TSC2) is crucial for inhibiting mTORC1 activity, thereby controlling cell size, division, and differentiation. The functional integrity of hamartin is vital for maintaining cellular homeostasis and preventing uncontrolled cell proliferation. Its role extends to the coordination of cellular responses to environmental stressors, including nutrient availability and hypoxic conditions, illustrating its importance in various cellular processes beyond tumor suppression. The loss of hamartin function, due to mutations or downregulation, disrupts the balance of cell growth regulation, leading to pathological conditions such as tuberous sclerosis complex (TSC), characterized by the growth of benign tumors in multiple organs.
The inhibition of hamartin can occur through various mechanisms, impacting its ability to regulate the mTOR pathway effectively. Genetic mutations within the TSC1 gene are a primary cause of hamartin inhibition, leading to a loss of function that disrupts the TSC1/TSC2 complex and results in the constitutive activation of mTORC1 signaling. This aberrant activation promotes unchecked cell growth and proliferation, contributing to the development of the hamartomas typical of tuberous sclerosis complex. Additionally, post-translational modifications of hamartin, such as phosphorylation, can affect its stability and interaction with tuberin, potentially inhibiting its regulatory functions. Environmental factors, including hypoxia and nutrient deprivation, can also modulate hamartin's activity indirectly by affecting the cellular context in which the TSC1/TSC2 complex operates. Understanding the complex mechanisms underlying the inhibition of hamartin provides crucial insights into the regulation of cell growth and the molecular pathology of diseases associated with its dysfunction, highlighting the importance of maintaining the delicate balance of signaling pathways within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin is an immunosuppressive drug and an mTOR inhibitor. It indirectly inhibits the function of TSC1-TSC2 complex by inhibiting mTORC1, which is a downstream effector of the complex. | ||||||
Everolimus | 159351-69-6 | sc-218452 sc-218452A | 5 mg 50 mg | $128.00 $638.00 | 7 | |
Similar to rapamycin, everolimus is an mTOR inhibitor. It indirectly affects the TSC1-TSC2 complex through mTORC1 inhibition. | ||||||
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $76.00 $148.00 | 9 | |
FK506 is another immunosuppressive drug that inhibits the activity of calcineurin, which indirectly influences the mTOR pathway and TSC1-TSC2 complex. | ||||||
BEZ235 | 915019-65-7 | sc-364429 | 50 mg | $207.00 | 8 | |
This is a dual PI3K/mTOR inhibitor that may impact the mTOR pathway and affect TSC1-TSC2 complex function. | ||||||
Torin 1 | 1222998-36-8 | sc-396760 | 10 mg | $240.00 | 7 | |
Torin1 is a potent ATP-competitive mTOR inhibitor that indirectly affects TSC1-TSC2 complex function. | ||||||
AZD8055 | 1009298-09-2 | sc-364424 sc-364424A | 10 mg 50 mg | $160.00 $345.00 | 12 | |
AZD8055 is an mTOR kinase inhibitor that may indirectly influence TSC1-TSC2 complex activity. | ||||||
GSK2126458 | 1086062-66-9 | sc-364503 sc-364503A | 2 mg 10 mg | $260.00 $1029.00 | ||
This is a selective mTOR inhibitor that indirectly affects TSC1-TSC2 complex signaling. | ||||||
INK 128 | 1224844-38-5 | sc-364511 sc-364511A | 5 mg 50 mg | $315.00 $1799.00 | ||
INK 128 is an investigational dual mTORC1/mTORC2 inhibitor that may impact the mTOR pathway and TSC1-TSC2 complex function. | ||||||
WYE-125132 | 1144068-46-1 | sc-364651 sc-364651A | 10 mg 50 mg | $510.00 $1536.00 | ||
WYE-125132 is an mTOR kinase inhibitor that may have an indirect effect on TSC1-TSC2 complex signaling. | ||||||